236 related articles for article (PubMed ID: 11868935)
1. Interactions of integrins with their partner proteins in leukocyte membranes.
Petty HR; Worth RG; Todd RF
Immunol Res; 2002; 25(1):75-95. PubMed ID: 11868935
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
Kindzelskii AL; Laska ZO; Todd RF; Petty HR
J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
4. Interaction of GPI-anchored cell surface proteins and complement receptor type 3.
Stockinger H
Exp Clin Immunogenet; 1997; 14(1):5-10. PubMed ID: 9187916
[TBL] [Abstract][Full Text] [Related]
5. Ectodomain interactions of leukocyte integrins and pro-inflammatory GPI-linked membrane proteins.
Petty HR; Kindzelskii AL; Adachi Y; Todd RF
J Pharm Biomed Anal; 1997 Jun; 15(9-10):1405-16. PubMed ID: 9226570
[TBL] [Abstract][Full Text] [Related]
6. Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.
Weinand RG; Rosenspire AJ; Petty HR
J Theor Biol; 1999 Mar; 197(2):217-25. PubMed ID: 10074395
[TBL] [Abstract][Full Text] [Related]
7. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alphaMbeta2 headpiece and reorientation of its transmembrane domains.
Tang ML; Vararattanavech A; Tan SM
J Biol Chem; 2008 Sep; 283(37):25392-25403. PubMed ID: 18644795
[TBL] [Abstract][Full Text] [Related]
10. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
Xue W; Kindzelskii AL; Todd RF; Petty HR
J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
[TBL] [Abstract][Full Text] [Related]
11. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
12. Protease crosstalk with integrins: the urokinase receptor paradigm.
Chapman HA; Wei Y
Thromb Haemost; 2001 Jul; 86(1):124-9. PubMed ID: 11486997
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Yebra M; Goretzki L; Pfeifer M; Mueller BM
Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
[TBL] [Abstract][Full Text] [Related]
14. Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils.
Sitrin RG; Johnson DR; Pan PM; Harsh DM; Huang J; Petty HR; Blackwood RA
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):233-41. PubMed ID: 12933356
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
Reuning U; Magdolen V; Hapke S; Schmitt M
Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
Tang ML; Kong LS; Law SK; Tan SM
Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection.
Veettil MV; Sadagopan S; Sharma-Walia N; Wang FZ; Raghu H; Varga L; Chandran B
J Virol; 2008 Dec; 82(24):12126-44. PubMed ID: 18829766
[TBL] [Abstract][Full Text] [Related]
18. Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils.
Kindzelskii AL; Eszes MM; Todd RF; Petty HR
Biophys J; 1997 Oct; 73(4):1777-84. PubMed ID: 9336173
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases.
Melchior A; Denys A; Deligny A; Mazurier J; Allain F
Exp Cell Res; 2008 Feb; 314(3):616-28. PubMed ID: 18054915
[TBL] [Abstract][Full Text] [Related]
20. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
Tang CH; Hill ML; Brumwell AN; Chapman HA; Wei Y
J Cell Sci; 2008 Nov; 121(Pt 22):3747-56. PubMed ID: 18940913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
